Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,707,100
+$4,995,380 QoQ
Shares Held
185,250
+39.0% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#95
of 421 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $24,174,742 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (40.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
85,841 | $14,467,642 | |
| 2 | ALKS |
Alkermes plc.
This page
|
185,250 | $9,707,100 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,707,100 | 185,250 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,711,720 | 133,250 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,728,335 | 133,250 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,820,000 | 94,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,115,790 | 39,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,287,780 | 39,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,243,251 | 77,999 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,722,670 | 133,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,615,000 | 150,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,977,700 | 110,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,431,600 | 340,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $10,363,700 | 370,000 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,955,000 | 350,000 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,805,650 | 135,000 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,919,500 | 150,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,349,500 | 150,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,468,500 | 150,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $4,735,800 | 180,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,884,600 | 210,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,476,400 | 210,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,585,360 | 309,354 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,910,732 | 209,354 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,176,612 | 209,354 | Shares | Sole | 2021-01-19 | |
| 2020-06-30 | $6,017,100 | 310,000 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $5,753,580 | 399,000 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||